Previous studies have proved that GSTP1 was variably expressed in malignant tumor tissues with a low level in lymphoma and breast cancer, while over-expressed were found in lung cancer, head and neck tumors and colon cancer [45]. Here, GSTP1 is linked to head and neck neoplasm.